- Issue Number:Volume 18 - Issue 3 - March 2010
The NY Times reported that the FDA has “cracked down” on dermatologist Dr. Leslie Baumann for expressing premature enthusiasm for an anti-wrinkle botulinum toxin product she was studying as an investigator in research trials.1 The FDA’s January 11, 2010, letter to Dr. Baumann cited the following FDA regulation as the basis for its concern about promotional statements she reportedly made in several magazines and on NBC’s Today Show.2
Skin & Aging Monthly Poll
Blog: Practice Management Pearls
West Chester, Pennsylvania
The Villages, Florida
New Haven, Connecticut

























